Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
Home › Stocks › Xylem Inc. (XYL) Stock Forecast & Price Prediction United States | NYSE | Industrials | Specialty Industrial Machinery
$125.27
-0.39 (-0.31%)10 Quality Stocks Worth Considering Now
Researching Xylem (XYL) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on XYL and similar high-potential opportunities.
Based on our analysis of 22 Wall Street analysts, XYL has a bullish consensus with a median price target of $139.00 (ranging from $116.00 to $172.00). The overall analyst rating is Strong Buy (8.1/10). Currently trading at $125.27, the median forecast implies a 11.0% upside. This outlook is supported by 13 Buy, 8 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Nathan Jones at Stifel, projecting a 37.3% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for XYL.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Apr 30, 2025 | RBC Capital | Deane Dray | Outperform | Maintains | $147.00 |
Apr 30, 2025 | Stifel | Nathan Jones | Buy | Maintains | $141.00 |
Apr 30, 2025 | Baird | Michael Halloran | Outperform | Maintains | $146.00 |
Apr 16, 2025 | Stifel | Nathan Jones | Buy | Maintains | $140.00 |
Apr 14, 2025 | Citigroup | Andrew Kaplowitz | Buy | Maintains | $134.00 |
Feb 5, 2025 | Baird | Michael Halloran | Outperform | Maintains | $148.00 |
Jan 24, 2025 | Stifel | Nathan Jones | Buy | Maintains | $150.00 |
Jan 13, 2025 | Citigroup | Andrew Kaplowitz | Buy | Maintains | $147.00 |
Dec 12, 2024 | Wolfe Research | Brad Hewitt | Peer Perform | Downgrade | $0.00 |
Dec 11, 2024 | Stifel | Nathan Jones | Buy | Maintains | $166.00 |
Dec 9, 2024 | Citigroup | Andrew Kaplowitz | Buy | Upgrade | $148.00 |
Nov 6, 2024 | TD Cowen | Joseph Giordano | Hold | Maintains | $125.00 |
Nov 1, 2024 | Baird | Michael Halloran | Outperform | Maintains | $154.00 |
Nov 1, 2024 | RBC Capital | Deane Dray | Outperform | Maintains | $162.00 |
Sep 3, 2024 | TD Cowen | Joseph Giordano | Hold | Downgrade | $138.00 |
Aug 13, 2024 | UBS | Damian Karas | Buy | Initiates | $165.00 |
Jul 31, 2024 | Baird | Michael Halloran | Outperform | Maintains | $170.00 |
Jul 31, 2024 | RBC Capital | Deane Dray | Outperform | Maintains | $163.00 |
Jul 31, 2024 | Stifel | Nathan Jones | Buy | Maintains | $172.00 |
Jul 18, 2024 | Stifel | Nathan Jones | Buy | Maintains | $170.00 |
The following stocks are similar to Xylem based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Xylem Inc. has a market capitalization of $30.46B with a P/E ratio of 33.7x. The company generates $8.60B in trailing twelve-month revenue with a 10.5% profit margin.
Revenue growth is +1.8% quarter-over-quarter, while maintaining an operating margin of +12.1% and return on equity of +8.5%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Provides global water technology solutions.
The company designs, manufactures, and delivers products for water and wastewater applications, generating revenue through sales of pumps, valves, and treatment equipment primarily to municipal, industrial, and agricultural sectors.
Xylem plays a vital role in environmental management and innovation, addressing global water challenges such as scarcity and sustainability. Headquartered in Rye Brook, New York, it operates globally and emphasizes research and development to enhance water system efficiency.
Industrials
Specialty Industrial Machinery
23,000
Mr. Matthew Francis Pine
United States
2011
Sector ETF report for CGW
Xylem Inc. (NYSE: XYL) declared a Q2 dividend of $0.40 per share, payable on June 26, 2025, to shareholders of record as of May 29, 2025. The company reported $8.6 billion in revenue for 2024.
Xylem's dividend declaration signals financial stability and shareholder return, indicating confidence in future earnings, which can attract investors seeking income and growth potential.
Since 2019, utilities and businesses have reused 18.1 billion cubic meters of water with solutions from Xylem, a global leader in water technology.
The reuse of 18.1 billion cubic meters of water highlights growing demand for water conservation technologies, potentially boosting Xylem's market position and attracting investor interest.
XYL benefits from strong end-market performance, a solid backlog, and the Evoqua acquisition, but may face margin pressures due to rising operating costs and expenses.
XYL's strong end markets and backlog suggest growth potential, while the Evoqua acquisition may enhance its portfolio. However, rising costs could pressure profit margins, impacting overall profitability.
Xylem Inc. (NYSE:XYL) will host its Q1 2025 Earnings Conference Call on April 29, 2025, at 9:00 AM ET, featuring key executives and analysts from various firms.
Xylem's Q1 earnings call signals upcoming financial performance insights, influencing stock valuation and investor sentiment. Analyst participation indicates market interest and potential volatility.
Xylem Inc. (NYSE: XYL) reported Q1 2025 revenue of $2.1 billion, with EPS up 10% reported and 14% adjusted, despite foreign exchange challenges. Results surpassed expectations.
Xylem Inc.'s strong first-quarter results and increased earnings per share indicate robust demand and effective execution, signaling potential growth and stability for investors.
Xylem (XYL) reported Q3 earnings of $1.03 per share, exceeding the Zacks Consensus Estimate of $0.95, and up from $0.90 per share in the same quarter last year.
Xylem's earnings beat estimates and show year-over-year growth, indicating strong financial performance and potentially increased investor confidence and stock value.
Based on our analysis of 22 Wall Street analysts, Xylem Inc. (XYL) has a median price target of $139.00. The highest price target is $172.00 and the lowest is $116.00.
According to current analyst ratings, XYL has 13 Buy ratings, 8 Hold ratings, and 0 Sell ratings. The stock is currently trading at $125.27. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict XYL stock could reach $139.00 in the next 12 months. This represents a 11.0% increase from the current price of $125.27. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company designs, manufactures, and delivers products for water and wastewater applications, generating revenue through sales of pumps, valves, and treatment equipment primarily to municipal, industrial, and agricultural sectors.
The highest price target for XYL is $172.00 from Nathan Jones at Stifel, which represents a 37.3% increase from the current price of $125.27.
The lowest price target for XYL is $116.00 from at , which represents a -7.4% decrease from the current price of $125.27.
The overall analyst consensus for XYL is bullish. Out of 22 Wall Street analysts, 13 rate it as Buy, 8 as Hold, and 0 as Sell, with a median price target of $139.00.
Stock price projections, including those for Xylem Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.